Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-13-000045

Scief Scientific Officer acquired 19,753,086 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

NIGALAYE ASHOK G · Scief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2013-09-10 Conversion : show line 1 in the form +19,753,086 $0.02 $480,000 22,455,550 I

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2013-09-10 Conversion : show line 2 in the form Series E Convertible Preferred Stock −1,600 0 I
Loading xslF345X03/primary_doc.xml…